HPTN 083-01 is a clinical trial examining whether injectable cabotegravir (CAB) for PrEP (pre-exposure prophylaxis) is a safe and acceptable method of HIV prevention for adolescents assigned male at birth.
Complete this form to see if you are eligible.
Please click Submit below to finish completing the survey. If you are eligible for the study, you will be contacted to set up a screening appointment.